Christophersen; Nicolaj Stroeyer
Patent Applications and Registrations
Patent applications and USPTO patent grants for Christophersen; Nicolaj Stroeyer.The latest application filed is for "generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors".
- Christophersen; Nicolaj Stroeyer - Virum DK
| Patent | Date |
|---|---|
| Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors Grant 11,274,280 - Christophersen , et al. March 15, 2 | 2022-03-15 |
| Generation Of Functional Beta Cells From Human Pluripotent Stem Cell-derived Endocrine Progenitors App 20210230554 - Christophersen; Nicolaj Stroeyer ; et al. | 2021-07-29 |
| Generation of Endocrine Progenitor Cells from Human Pluripotent Stem Cells Using Small Molecules App 20200002670 - Doehn; Ulrik ; et al. | 2020-01-02 |
| Generation of Functional Beta Cells From Human Pluripotent Stem Cell-Derived Endocrine Progenitors App 20190085295 - Christophersen; Nicolaj Stroeyer ; et al. | 2019-03-21 |
| Generation of Endocrine Progenitor Cells from Human Pluripotent Stem Cells Using Small Molecules App 20160208215 - Doehn; Ulrik ; et al. | 2016-07-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 